Top 2024 dvm360 podcasts: #4
A Top 5 episode of dvm360's The Vet Blast Podcast is revealed in our 2024 countdown.
The Vet Blast Podcast hosted by Adam Christman, DVM, MBA, chief veterinary officer of dvm360, and edited by dvm360’sCaitlin McCafferty, featured a wide variety of veterinary topics and guests throughout the past year. As 2024 draws to a close, dvm360 is looking back and celebrating the Top 5 podcasts, as measured by audience interest and engagement. Through, New Year’s Eve, dvm360 is counting down the Top 5 podcasts by sharing 1 of these episodes per day.
The following podcast is #4 on the list and features guest Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ, founder and editor of CriticalCareDVM.com. They discuss recent advancements in FIP treatment, emphasizing the importance of accurate diagnosis, and more.
The following is a partial transcript
Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ: Historically, treatment of FIP has included medications like prednisolone, interferon and polyprenyl immunostimulant, and as the listeners know, these treatments have been largely unsuccessful and often resulted in euthanasia. Our colleagues in the United Kingdom and Australia have had legal access to something called GS 5734, more commonly known as remdesivir. This is a prodrug of GS 441524, with an extra chemical side chain that is supposed to improve cellular penetration. They're really lucky. They have access to both injectable and oral forms, and there are established protocols in these geographic locales for each route of administration.
In the USA, we currently have no FDA approved treatments for treatment of FIP. However, Stokes Pharmacy, a PCAB accredited compounding pharmacy, has recently established an exclusive partnership with the Bova Group to offer a US made oral treatment for FIP so American veterinarians can now manage their FIP patients with Stokes Pharmacy's compounded preparation that is supported by Bova's, unique drug formula that's been utilized in clinical research studies across the globe.
Subscribe to The Vet Blast Podcast on Apple Podcasts, Spotify, or wherever you get your podcasts.
Podcast CE: Using Novel Targeted Treatment for Canine Allergic and Atopic Dermatitis
December 20th 2024Andrew Rosenberg, DVM, and Adam Christman, DVM, MBA, talk about shortcomings of treatments approved for canine allergic and atopic dermatitis and react to the availability of a novel JAK inhibitor.
Listen
